TERESINA JENSEN: Open Payments
NPI 1760140982 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,063 in 110 payments from 22 companies in 2025. Trend: 2023 $1,399 · 2024 $2,032 · 2025 $3,063
Food & beverage: $2,944Education: $119
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $1,174 |
| Lilly USA, LLC | 10 | $394 |
| Organon LLC | 7 | $258 |
| ABBVIE INC. | 11 | $200 |
| Incyte Corporation | 9 | $193 |
| Regeneron Healthcare Solutions, Inc. | 11 | $173 |
| UCB, Inc. | 4 | $118 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| GENZYME CORPORATION | 4 | $89 |
| Organogenesis Inc. | 3 | $69 |
Products named: TREMFYA, EBGLYSS, DUPIXENT, OPZELURA, VTAMA, SKYRIZI, Bimzelx, TALTZ.
Industry payments across DE — which companies pay providers there.
